Search hospitals > Michigan > Ann Arbor
University of Michigan Comprehensive Cancer Center
Claim this profileAnn Arbor, Michigan 48109
Global Leader in Parotid Gland Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Cancer
Conducts research for Prostate Cancer
856 reported clinical trials
60 medical researchers
Summary
University of Michigan Comprehensive Cancer Center is a medical facility located in Ann Arbor, Michigan. This center is recognized for care of Parotid Gland Cancer, Breast Cancer, Lung Cancer, Cancer, Prostate Cancer and other specialties. University of Michigan Comprehensive Cancer Center is involved with conducting 856 clinical trials across 653 conditions. There are 60 research doctors associated with this hospital, such as Paul Swiecicki, Rashmi Chugh, MD, Vaibhav Sahai, MBBS, MS, and Francis P. Worden.Area of expertise
1Parotid Gland Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
HER2 negative
HER2 positive
Top PIs
Paul SwiecickiUniversity of Michigan Comprehensive Cancer Center5 years of reported clinical research
Studies Parotid Gland Cancer
Studies Melanoma
19 reported clinical trials
29 drugs studied
Rashmi Chugh, MDUniversity of Michigan5 years of reported clinical research
Expert in Soft Tissue Sarcoma
Studies Uterine Leiomyosarcoma
19 reported clinical trials
26 drugs studied
Vaibhav Sahai, MBBS, MSUniversity of Michigan Comprehensive Cancer Center6 years of reported clinical research
Studies Pancreatic Cancer
Studies Parotid Gland Cancer
16 reported clinical trials
28 drugs studied
Francis P. WordenUniversity of Michigan6 years of reported clinical research
Studies Parotid Gland Cancer
Studies Thyroid Cancer
13 reported clinical trials
23 drugs studied
Clinical Trials running at University of Michigan Comprehensive Cancer Center
Breast Cancer
Parotid Gland Cancer
Cancer
Pancreatic Cancer
Breast cancer
Ovarian Cancer
Lung Cancer
Lymphoma
Prostate Cancer
Skin Cancer
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint High 2 Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of Michigan Comprehensive Cancer Center?
Where is University of Michigan Comprehensive Cancer Center located?
Who should I call to ask about financial aid or insurance network?
What insurance does University of Michigan Comprehensive Cancer Center accept?
What awards or recognition has University of Michigan Comprehensive Cancer Center received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.